Thank you, Mr. Chair.
Thank you for being here. I think all of us agree that whenever you're here, it's a great eye-opener. You certainly do give us good direction.
I have just a quick question, perhaps for Ms. Hillman.
With the allegations that the TPP will increase the cost of drugs because of the patent rights, wouldn't there also be an argument that there would be more people in the playing field and therefore more competition, which would drive down the cost of drugs?